Verva’s scientists will be presentating and publishing the results of Verva’s Research and Development programs. Selected publications to date are included below:
VVP808
Walder K, Konstantopoulos N, Windmill K, Molero-Navajas J, Krippner G, Collier G. [Abstract]. Mechanism of action of VVP808: A novel insulin sensitising agent. European Association for the Study of Diabetes Annual Meeting. Lisbon, Portugal. 12-16 September 2011.
GES Technology
Konstantopoulos N, Foletta VC, Segal DH, Shields KA, Sanigorski A, Windmill K, Swinton C, Connor T, Wanyonyi S, Dyer TD, Fahey RP, Watt RA, Curran JE, Molero JC, Krippner G, Collier GR, James DE, Blangero J, Jowett JB, Walder KR. (2011). A gene expression signature for insulin resistance. Physiol Genomics 43(3): 110-20. (PMID 21081660)